Nonpathogenic Escherichia coli Strain Nissle 1917 Inhibits Signal Transduction in Intestinal Epithelial Cells

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Infection and Immunity

• Publication date

  2007-10-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/IAI.01193-07PMID 17967864PMCID PMC2223654
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Induction of Human β-Defensin 2 by the Probiotic Escherichia coli Nissle 1917 Is Mediated through Flagellin

  2007cited by this paper
• Paneth cells, defensins, and the commensal microbiota: a hypothesis on intimate interplay at the intestinal mucosa.

  2007cited by this paper
• Epithelia: lymphocyte interactions in the gut

  2007cited by this paper
• Escherichia coli Strain Nissle 1917 Ameliorates Experimental Colitis via Toll-Like Receptor 2- and Toll-Like Receptor 4-Dependent Pathways

  2006cited by this paper
• Colostomy: formation and closure

  2006cited by this paper
• Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis

  2006cited by this paper
• Nonpathogenic Escherichia coli Strain Nissle1917 Prevents Murine Acute and Chronic Colitis

  2005cited by this paper
• Novel pathophysiological concepts of inflammatory bowel disease

  2005cited by this paper
• Mechanisms of Disease: defensins in gastrointestinal diseases

  2005cited by this paper
• Escherichia coli Nissle 1917 Distinctively Modulates T-Cell Cycling and Expansion via Toll-Like Receptor 2 Signaling

  2005cited by this paper
• Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells

  2005cited by this paper
• Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine

  2004cited by this paper
• Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics.

  2004influential reference
• Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis.

  2004cited by this paper
• Preventive Effects of Escherichia coli Strain Nissle 1917 on Acute and Chronic Intestinal Inflammation in Two Different Murine Models of Colitis

  2004cited by this paper
• Probiotics inhibit nuclear factor-kappaB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition.

  2004cited by this paper
• Live Lactobacillus rhamnosus [corrected] is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression.

  2004cited by this paper
• NF-κB- and AP-1-Mediated Induction of Human Beta Defensin-2 in Intestinal Epithelial Cells by Escherichia coli Nissle 1917: a Novel Effect of a Probiotic Bacterium

  2004cited by this paper
• DNA from probiotic bacteria modulates murine and human epithelial and immune function.

  2004influential reference
• Live Lactobacillus reuteri Is Essential for the Inhibitory Effect on Tumor Necrosis Factor Alpha-Induced Interleukin-8 Expression

  2004cited by this paper
• Inflammatory bowel disease.

  2002cited by this paper
• A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

  2001cited by this paper
• Monocyte differentiation in intestine‐like macrophage phenotype induced by epithelial cells

  2001cited by this paper
• Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

  2001cited by this paper
• Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination.

  2000cited by this paper
• Prokaryotic Regulation of Epithelial Responses by Inhibition of IκB-α Ubiquitination

  2000cited by this paper
• Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial.

  1999cited by this paper
• Double‐blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis

  1997cited by this paper
• A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion.

  1995cited by this paper
• Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice.

  1993cited by this paper
• Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression.

  1993cited by this paper
• Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene.

  1993cited by this paper
• Double blind, placebo controlled trial of metronidazole in Crohn's disease.

  1991cited by this paper
• lnterleukin-10-Deficient Mice Develop Chronic Enterocolitis

  year unknowncited by this paper

• Cellular Nanoparticle-Probiotic Biohybrid for Multimodal Oral Therapy of Food Allergy.

  2026cites this paper
• Antibiotics and Opportunities of Their Alternatives in Pig Production: Mechanisms Through Modulating Intestinal Microbiota on Intestinal Health and Growth

  2025cites this paper
• A Critical Review on the Role of Probiotics in Lung Cancer Biology and Prognosis.

  2024cites this paper
• Probiotic Escherichia coli Nissle 1917 propelled micro-robot with pH sensitivity for hypoxia targeted intestinal tumor therapy.

  2023cites this paper
• Evaluation of microbial and vancomycin treatments in ulcerative colitis in murine models

  2023cites this paper
• Identification and expression profiling of c-di-GMP signaling genes in the probiotic strain Escherichia coli Nissle 1917 during adhesion to the intestinal epithelial cells

  2023cites this paper
• Antibacterial MccM as the Major Microcin in Escherichia coli Nissle 1917 against Pathogenic Enterobacteria

  2023cites this paper
• 장내 미생물을 이용한 염증성 장질환의 치료적 접근

  2021cites this paper
• Application of the “SCOBY” and Kombucha Tea for the Production of Fermented Milk Drinks

  2021cites this paper
• Lactobacillus Protects Against S. Typhimurium-Induced Intestinal Inflammation by Determining the Fate of Epithelial Proliferation and Differentiation.

  2020cites this paper
• Nutritional support and probiotics as potential treatment in IBD.

  2020cites this paper
• The Immunomodulatory Properties of Extracellular Vesicles Derived from Probiotics: A Novel Approach for the Management of Gastrointestinal Diseases

  2019cites this paper
• Investigating the potential of biosurfactants in the control of tooth infections

  2019cites this paper
• Cellular and Mucosal Immune Responses Following Vaccination with Inactivated Mutant of Escherichia coli O157:H7

  2019cites this paper
• CRISPR‐based curing and analysis of metabolic burden of cryptic plasmids in Escherichia coli Nissle 1917

  2019cites this paper
• An adherent mucus layer attenuates the genotoxic effect of colibactin

  2018cites this paper
• Salmonella infection - prevention and treatment by antibiotics and probiotic yeasts: a review.

  2018cites this paper
• Suppression of Intestinal Epithelial Cell Chemokine Production by Lactobacillus rhamnosus R0011 and Lactobacillus helveticus R0389 Is Mediated by Secreted Bioactive Molecules

  2018cites this paper
• In Vitro Evaluation of the Impact of the Probiotic E. coli Nissle 1917 on Campylobacter jejuni’s Invasion and Intracellular Survival in Human Colonic Cells

  2017cites this paper
• Gut Microbiota Species Can Provoke both Inflammatory and Tolerogenic Immune Responses in Human Dendritic Cells Mediated by Retinoic Acid Receptor Alpha Ligation

  2017cites this paper
• The Probiotic Compound VSL#3 Modulates Mucosal, Peripheral, and Systemic Immunity Following Murine Broad-Spectrum Antibiotic Treatment

  2017cites this paper
• Using murine colitis models to analyze probiotics-host interactions.

  2017cites this paper
• Intestinal-borne dermatoses significantly improved by oral application of Escherichia coli Nissle 1917.

  2016cites this paper
• Characterizing immunomodulatory activity of lactic acid bacteria on cell types involved in innate immunity: Analysis of the effects of Lactobacillus rhamnosus R0011-derived milk ferments on macrophage polarization and of secretome effects on intestinal epithelial cell cytokine production

  2015cites this paper
• Bacterial Secretions of Nonpathogenic Escherichia coli Elicit Inflammatory Pathways: a Closer Investigation of Interkingdom Signaling

  2015cites this paper
• In vitro modulation of tumor necrosis factor α production in THP-1 cells by lactic acid bacteria isolated from healthy human infants.

  2015cites this paper
• Lactococcus lactis ssp. lactis biovar. diacetylactis UL719 et la nisine : une nouvelle approche dans le traitement des infections à Clostridium difficile

  2015cites this paper
• Fructooligosaccharides decreased the ability of probiotic Escherichia coli Nissle 1917 to adhere to co-cultures of human intestinal cell lines

  2015cites this paper
• The gut microbiota and inflammatory bowel disease

  2014cites this paper
• Chemopreventive Potential of Probiotics and Prebiotics

  2014cites this paper
• [The role of Escherichia coli strain Nissle 1917 in the gastro-intestinal diseases].

  2014cites this paper
• Probiotic Escherichia coli Nissle 1917 and Commensal E. coli K12 Differentially Affect the Inflammasome in Intestinal Epithelial Cells

  2014cites this paper
• Investigation of host-microbe interactions in the probiotic bacteria Escherichia coli Nissle 1917

  2014cites this paper
• Role of F1C Fimbriae, Flagella, and Secreted Bacterial Components in the Inhibitory Effect of Probiotic Escherichia coli Nissle 1917 on Atypical Enteropathogenic E. coli Infection

  2014cites this paper
• Lactobacillus paracasei and Lactobacillus plantarum strains downregulate proinflammatory genes in an ex vivo system of cultured human colonic mucosa

  2013cites this paper
• Exploring the ameliorative potential of probiotic Dahi containing Lactobacillus acidophilus and Bifidobacterium bifidum on dextran sodium sulphate induced colitis in mice

  2013cites this paper
• Lactic acid bacteria and bifidobacteria attenuate the proinflammatory response in intestinal epithelial cells induced by Salmonella enterica serovar Typhimurium.

  2013cites this paper
• [Lactobacillus rhamnosus GG supplementation to reduce side-effects of anti-Helicobacter pylori treatment].

  2013cites this paper
• Probiotic-derived factors for the treatment and prevention of 5-fluorouracil-induced intestinal mucositis.

  2013cites this paper
• Transcriptomic response of immune signalling pathways in intestinal epithelial cells exposed to lipopolysaccharides, Gram-negative bacteria or potentially probiotic microbes.

  2012cites this paper
• Characterization of novel probiotics and prebiotics

  2012cites this paper
• Anti-inflammatory modulation of immune response by probiotic Escherichia coli Nissle 1917 in human blood mononuclear cells

  2012cites this paper
• Molekulare Interaktionen von Milchsäurebakterien mit enterohämorrhagischen Escherichia coli und humanen Darmepithelzellen

  2011cites this paper
• Potential Probiotic Kluyveromyces marxianus B0399 Modulates the Immune Response in Caco-2 Cells and Peripheral Blood Mononuclear Cells and Impacts the Human Gut Microbiota in an In Vitro Colonic Model System

  2011cites this paper
• Bovine dendritic cells & their interaction with E.coli 0157:H7

  2011cites this paper
• Probiotic factors partially improve parameters of 5-fluorouracil-induced intestinal mucositis in rats

  2011cites this paper
• The Probiotic Escherichia coli Nissle 1917 Reduces Pathogen Invasion and Modulates Cytokine Expression in Caco-2 Cells Infected with Crohn's Disease-Associated E. coli LF82

  2011influential citation
• E. coli Nissle 1917 Affects Salmonella Adhesion to Porcine Intestinal Epithelial Cells

  2011cites this paper
• Escherichia coli Nissle 1917 (Mutaflor): New Insights into an Old Probiotic Bacterium

  2011cites this paper
• Regulation of the Polymeric Immunoglobulin Receptor in Intestinal Epithelial Cells by Enterobacteriaceae: Implications for Mucosal Homeostasis

  2010cites this paper
• Probiotics: progress toward novel therapies for intestinal diseases

  2010cites this paper
• Inhibitory effects of Lactobacillus casei subsp. rhamnosus on Salmonella lipopolysaccharide-induced inflammation and epithelial barrier dysfunction in a co-culture model using Caco-2/peripheral blood mononuclear cells.

  2010cites this paper
• Molecular crosstalk of probiotic bacteria with the intestinal immune system: clinical relevance in the context of inflammatory bowel disease.

  2010cites this paper
• Probiotics and the gut microbiota in intestinal health and disease

  2010cites this paper
• Decisive role of lipopolysaccharide in activating nitric oxide and cytokine production by the probiotic Escherichia coli strain Nissle 1917

  2010cites this paper
• Mechanisms of probiotic actions - A review.

  2010cites this paper
• The K5 Capsule of Escherichia coli Strain Nissle 1917 Is Important in Mediating Interactions with Intestinal Epithelial Cells and Chemokine Induction

  2009cites this paper
• Post-Translational Inhibition of IP-10 Secretion in IEC by Probiotic Bacteria: Impact on Chronic Inflammation

  2009cites this paper
• Probiotics and their derivatives as treatments for inflammatory bowel disease.

  2009cites this paper
• The non-pathogenic Escherichia coli strain Nissle 1917 – features of a versatile probiotic

  2009cites this paper
• Therapeutic effects of four strains of probiotics on experimental colitis in mice.

  2009cites this paper
• Characterisation of Escherichia coli of the bovine intestinal tract

  2009influential citation
• Probiotics and Prebiotics in Inflammatory Bowel Disease

  2009cites this paper
• Correction: Post-Translational Inhibition of IP-10 Secretion in IEC by Probiotic Bacteria: Impact on Chronic Inflammation

  2009cites this paper
• Probiotics and Gastrointestinal Disease: Clinical Evidence and Basic Science.

  2009cites this paper
• Malnutrition as an enteric infectious disease with long-term effects on child development.

  2008cites this paper
• The mother's immune system is a balanced threat to the foetus, turning to protection of the neonate

  2008influential citation